课题基金 / 基金详情

The Androgen Receptor Signaling in Prostate Cancers

The Androgen Receptor Signaling in Prostate Cancers
前列腺癌中的雄激素受体信号传导
批准号:
307126
负责人:
Dong Xuesen
金额:
$55.59万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-03-01 至 2019-03-01

项目摘要

项目成果

Dong Xuesen的其他基金

相似基金

相关文献

中文摘要
翻译
雄激素是由睾丸产生和分泌的激素。它们与前列腺癌密切相关。这些激素通过激活细胞内一种叫做雄激素受体(AR)的蛋白质来起作用。AR控制着特定基因的水平
英文摘要
Androgens are hormones produced and secreted by the testes. They have been strongly implicated in prostate cancers. These hormones act by activating a protein inside the cell called the androgen receptor (AR). The AR controls the levels of specific genes
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Design a Double-Bolt Lock to Control Cancer Cell Growth
  • 批准号:
    443354
  • 项目类别:
    Operating Grants
  • 资助金额:
    $66.32万
  • 财政年份:
    2021
  • 负责人:
    Dong Xuesen
  • 依托单位:
RNA splicing regulates prostate cancer progression to hormone therapy resistant neuroendocrine tumors
  • 批准号:
    370828
  • 项目类别:
    Operating Grants
  • 资助金额:
    $50.99万
  • 财政年份:
    2017
  • 负责人:
    Dong Xuesen
  • 依托单位:
Androgen Receptor Corepressors, PSF and p54nrb, in Prostate Cancer
Steroid Receptor Corepressors, PSF and p54nrb, in Prostate Cancer
海外基金